This Arrowhead Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
First Solar, Inc.
BLOOM ENERGY CORP
Arrowhead Pharmaceuticals, Inc.
RXO, Inc. Common Stock
Ambiq Micro, Inc.
First Solar, Inc. FSLR | 0.00 | |
BLOOM ENERGY CORP BE | 0.00 | |
Arrowhead Pharmaceuticals, Inc. ARWR | 0.00 | |
RXO, Inc. Common Stock RXO | 0.00 | |
Ambiq Micro, Inc. AMBQ | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BMO Capital analyst Fadi Chamoun initiated coverage on RXO Inc (NYSE:RXO) with an Outperform rating and announced a price target of $35. RXO shares closed at $27.09 on Monday. See how other analysts view this stock.
- Roth Capital analyst Suji Desilva initiated coverage on Ambiq Micro Inc (NYSE:AMBQ) with a Buy rating and announced a price target of $125. Ambiq Micro shares closed at $81.35 on Monday. See how other analysts view this stock.
- Truist Securities analyst Christopher Souther initiated coverage on Bloom Energy Corp (NYSE:BE) with a Hold rating and announced a price target of $250. Bloom Energy shares closed at $233.49 on Monday. See how other analysts view this stock.
- Stifel analyst James Condulis initiated coverage on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) with a Buy rating and announced a price target of $98. Arrowhead Pharma shares closed at $74.11 on Monday. See how other analysts view this stock.
- Truist Securities analyst Christopher Souther initiated coverage on First Solar Inc (NASDAQ:FSLR) with a Hold rating and announced a price target of $249. First Solar shares closed at $221.03 on Monday. See how other analysts view this stock.
Considering buying ARWR stock? Here’s what analysts think:
Photo via Shutterstock